About

Mr. Bloemhard has served as President of Healthcare & Water Technologies since November 2025. He previously led the global Water Solutions business as Vice President General Manager since January 2024.

From November 2022 to July 2023, Mr. Bloemhard served as the Chief Commercial Officer, Mobility & Materials, and later as Global Commercial VP, Industrial/Medical/Consumer, of Celanese. In 2018, as part of the Dow DuPont merger, he joined DuPont's Transportation & Advanced Polymers business unit as the Global Vice President and General Manager for Performance Resins, and was later appointed Chief Commercial Officer across DuPont's Engineering Polymers and Performance Resins businesses in April 2019. Prior to 2018, he spent over fourteen years at Dow Performance Chemicals in leadership roles across several different business lines. Mr. Bloemhard holds a bachelor's degree in International Business Studies from Hanze University in Groningen, The Netherlands.

Roles

DuPont de Nemours, Inc.
President, Healthcare & Water Technologies · Current role
2025–present
DuPont de Nemours, Inc.
Vice President General Manager, Water Solutions · Led the global Water Solutions business.
January 2024 – November 2025
Celanese
Chief Commercial Officer, Mobility & Materials; later Global Commercial VP, Industrial/Medical/Consumer
November 2022 – July 2023
DuPont de Nemours, Inc.
Global Vice President and General Manager, Performance Resins (Transportation & Advanced Polymers); later Chief Commercial Officer, Engineering Polymers and Performance Resins · Joined as part of the Dow DuPont merger in 2018; appointed Chief Commercial Officer in April 2019.
2018 – 2024
Dow Performance Chemicals
Leadership roles · Spent over fourteen years in leadership roles across several different business lines prior to 2018.

Fixed Compensation

FY 2025
Salary
$545,833
ComponentAnnual base salary
Bonus
$400,000
All other compensation
$84,354
Total compensation
$2,254,599

Performance Compensation

Data from FY 2025

Cash incentive

Annual cash incentive
$474,375
FormNon-Equity Incentive Plan Compensation
Target Opportunity
Evaluation periodFY2025

Stock awards

Stock awards
$750,037
FormAggregate grant date fair value

Also at DuPont de Nemours, Inc.

Related

See how VectorShift works for your firm

Request Demo